Biotest AG — Director's Dealing 2010

May 10, 2010

News Details

Directors’ Dealings | 10 May 2010 10:23

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Dr. Reinecke First name: Martin Company: Biotest AG Position: Seniour Vice President Plasma Alliances and Protein Supply Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Purchase Date: 06.05.2010 Price: 31.00 Currency: EUR No. of items: 250 Total amount traded: 7750.00 Place: Xetra Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 10.05.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 11283